The Role of Stem Cells in the Treatment of Cardiovascular Diseases.
Estera BakinowskaKajetan KiełbowskiDominika BoborykoAleksandra Wiktoria BratborskaJoanna Olejnik-WojciechowskaMarcin RusińskiAndrzej PawlikPublished in: International journal of molecular sciences (2024)
Cardiovascular diseases (CVDs) are the leading cause of death and include several vascular and cardiac disorders, such as atherosclerosis, coronary artery disease, cardiomyopathies, and heart failure. Multiple treatment strategies exist for CVDs, but there is a need for regenerative treatment of damaged heart. Stem cells are a broad variety of cells with a great differentiation potential that have regenerative and immunomodulatory properties. Multiple studies have evaluated the efficacy of stem cells in CVDs, such as mesenchymal stem cells and induced pluripotent stem cell-derived cardiomyocytes. These studies have demonstrated that stem cells can improve the left ventricle ejection fraction, reduce fibrosis, and decrease infarct size. Other studies have investigated potential methods to improve the survival, engraftment, and functionality of stem cells in the treatment of CVDs. The aim of the present review is to summarize the current evidence on the role of stem cells in the treatment of CVDs, and how to improve their efficacy.
Keyphrases
- stem cells
- mesenchymal stem cells
- heart failure
- cell therapy
- cardiovascular disease
- coronary artery disease
- atrial fibrillation
- cell death
- pulmonary hypertension
- bone marrow
- pulmonary artery
- umbilical cord
- high resolution
- metabolic syndrome
- drug induced
- mitral valve
- single molecule
- acute heart failure
- congenital heart disease
- cardiac resynchronization therapy